loading

Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
38.00%
28.27
45.59 58.94 62.01 60.64
Operating Income/Loss
38.00%
-28.27
-45.59 -58.94 -62.01 -60.64
Income/Loss From Continuing Operations Before Tax
39.26%
-26.30
-43.30 -56.17 -57.76 -55.85
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
39.26%
-26.30
-43.30 -56.17 -57.76 -55.85
Net Income/Loss
39.26%
-26.30
-43.30 -56.17 -57.76 -55.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.03%
61.41
61.39 61.22 60.73 60.38
Diluted Average Shares
0.03%
61.41
61.39 61.22 60.73 60.38
Basic Earnings Per Share
39.44%
-0.43
-0.71 -0.92 -0.95 -0.92
Diluted Earnings Per Share
39.44%
-0.43
-0.71 -0.92 -0.95 -0.92
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
Kapitalisierung:     |  Volumen (24h):